| Anti-Tryptase fab E104.v1 bound to tryptase | |
Heteromer
| 31-274 | 3×CA; 4×0GJ; |
| Assess |
| Complex between soybean trypsin inhibitor beta1-tryptase and a humanized fab | |
Heteromer
P01070; | 31-273 | 2×EDO; |
| Assess |
| Human beta-1 tryptase mutant Ile99Cys | | homo-4-mer | 31-274 | 7×SO4; 4×0GJ; |
| Assess |
| HUMAN BETA-TRYPTASE: A RING-LIKE TETRAMER WITH ACTIVE SITES FACING A CENTRAL PORE | | homo-4-mer | 31-274 | 4×APA; |
| Assess |
| Crystal Structure of the Recombinant Human Alpha I Tryptase Mutant K192Q/D216G in Complex with Leup… | | homo-4-mer | 31-273 | 2×NAG; 4×BU3; 2×NAG; |
| Assess |
| Human beta-tryptase co-crystal structure with (6S,8R)-N,N'-bis[3-({4-[3-(aminomethyl)phenyl]piperid… | | homo-4-mer | 31-273 | 4×MES; 8×SO4; 4×PG4; 2×X2A; |
| Assess |
| Human beta-tryptase co-crystal structure with [(1,1,3,3-tetramethyldisiloxane-1,3-diyl)di-1-benzofu… | | homo-4-mer | 31-273 | 4×CL; 4×PGE; 4×ACT; 2×2AJ; |
| Assess |
| Human tryptase with 2-amino benzimidazole | | homo-4-mer | 31-273 | 4×270; |
| Assess |
| Human beta-tryptase co-crystal structure with [(1,1,3,3-tetramethyldisiloxane-1,3-diyl)di-1-benzoth… | | homo-4-mer | 31-273 | 10×SO4; 4×CL; 4×PGE; 2×2AV; 2×MES; |
| Assess |
| beta-tryptase inhibitor | | homo-4-mer | 31-273 | 4×P43; |
| Assess |
| Potent, Nonpeptide Inhibitors of Human Mast Cell Tryptase | | homo-4-mer | 31-273 | 4×11N; |
| Assess |
| Crystal Structure of the Recombinant Human Alpha I Tryptase Mutant D216G | | homo-4-mer | 31-273 | 2×NAG; |
| Assess |
| human beta-II tryptase in complex with 4-(3-Aminomethyl-phenyl)- piperidin-1-yl-(5-phenethyl- pyrid… | | homo-4-mer | 31-273 | 4×PM2; |
| Assess |
| Human alpha1-tryptase | | homo-4-mer | 31-273 | |
| Assess |
| Human beta-tryptase co-crystal structure with {(1,1,3,3-tetramethyldisiloxane-1,3-diyl)bis[5-(methy… | | homo-4-mer | 31-273 | 10×SO4; 2×PG4; 2×X00; |
| Assess |
| human beta-tryptase II complexed with 4-piperidinebutyrate to make acylenzyme | | homo-4-mer | 31-273 | 4×C1R; |
| Assess |
| Human beta tryptase II with inhibitor CRA-28427 | | homo-4-mer | 31-273 | 4×C4A; |
| Assess |
| Crystal Structure of the Recombinant Human Alpha I Tryptase Mutant D216G in Complex with Leupeptin | | homo-4-mer | 31-273 | 1×NAG; 4×BU3; 1×NAG; |
| Assess |
| Crystal Structure of human tryptase with potent non-peptide inhibitor | | homo-4-mer | 31-273 | 4×2FF; |
| Assess |
| Human beta-tryptase co-crystal structure with (2R,4S)-N,N'-bis[3-({4-[3-(aminomethyl)phenyl]piperid… | | homo-4-mer | 31-273 | 2×2A4; 8×SO4; 4×MES; 2×CL; |
| Assess |
| Human beta II tryptase with inhibitor CRA-27592 | | homo-4-mer | 31-273 | 4×5AM; |
| Assess |
| Human beta-tryptase II with inhibitor CRA-29382 | | homo-4-mer | 31-273 | 4×C3A; |
| Assess |
| Potent, Nonpeptide Inhibitors of Human Mast Cell Tryptase | | homo-4-mer | 31-273 | 4×11M; |
| Assess |
| human beta tryptase II complexed with activated ketone inhibitor CRA-29382 | | homo-4-mer | 31-273 | 4×C3A; |
| Assess |
| Crystal Structure of Human Beta-Tryptase Complexed with a Synthetic Inhibitor with a Tropanylamide … | | homo-4-mer | 31-272 | 4×0GX; 2×CO3; |
| Assess |
| Human beta-tryptase co-crystal structure with 5-{4-[3-(aminomethyl)phenyl]piperidine-1-carbonyl}-2-… | | monomer | 31-273 | 1×Y35; 1×SO4; 1×PGE; |
| Assess |
| TRYPTASE B2 IN COMPLEX WITH 5-(3-Aminomethyl-phenoxymethyl)-3-[3-(2-chloro-pyridin-3-ylethynyl)-phe… | | monomer | 31-272 | 1×5TA; |
| Assess |